Cargando…

Medium-Term (Least 5 Years) Comparative Outcomes in Anterior Cruciate Ligament Reconstruction Using 4SHG, Allograft, and LARS Ligament

OBJECTIVE: To compare the clinical efficacy of anterior cruciate ligament (ACL) reconstruction with 4-strand hamstring tendon autograft (4SHG), allograft and the Ligament Advanced Reinforcement System (LARS) ligament, and to find the causes of cumulative failure or nonreturn to sport. DESIGN: Retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Mengdi, Jia, Xinyu, Zhang, Zaihang, Jin, Zhigao, Li, Yong, Dong, Qirong, Xu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Clinical Journal of Sport Medicine 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928216/
https://www.ncbi.nlm.nih.gov/pubmed/30855342
http://dx.doi.org/10.1097/JSM.0000000000000730
_version_ 1783659815874068480
author Su, Mengdi
Jia, Xinyu
Zhang, Zaihang
Jin, Zhigao
Li, Yong
Dong, Qirong
Xu, Wei
author_facet Su, Mengdi
Jia, Xinyu
Zhang, Zaihang
Jin, Zhigao
Li, Yong
Dong, Qirong
Xu, Wei
author_sort Su, Mengdi
collection PubMed
description OBJECTIVE: To compare the clinical efficacy of anterior cruciate ligament (ACL) reconstruction with 4-strand hamstring tendon autograft (4SHG), allograft and the Ligament Advanced Reinforcement System (LARS) ligament, and to find the causes of cumulative failure or nonreturn to sport. DESIGN: Retrospective case series. SETTING: Department of Orthopedic Surgery, the second affiliated hospital of Soochow University, Suzhou, Jiangsu, China. PATIENTS: Three hundred six patients with isolated ACL deficiency were included. Two hundred twenty-nine patients met the inclusion/exclusion criteria, and finally, 185 of these patients participated in this study. INTERVENTIONS: Anterior cruciate ligament reconstruction using 4SHG, allograft, and LARS. MAIN OUTCOME MEASURES: Objective knee function, subjective knee function, and information regarding return to sport, cumulative failure, and complications. Secondary: distribution of tunnel position and tunnel enlargement. RESULTS: There were no statistically significant differences between the 3 groups regarding all the clinical objective and subjective results, return to sport, complications, or cumulative failures (P > 0.05). One hundred twenty-eight patients (69.2%, 128/185) returned to sport. Preoperative (after injury) Tegner scores were inferior to postoperative Tegner scores, and postoperative Tegner scores were inferior to preinjury Tegner scores (P < 0.01). The femoral tunnel malposition was significantly associated with cumulative failure (P < 0.05). CONCLUSIONS: There were no statistically significant differences among the 4SHG, allograft, and LARS ligament in terms of the clinical outcomes after ACL reconstruction (ACLR) at 5-years follow-up. Interestingly, ACLR could improve the functional and motorial level of the knee, but patients had great difficulty in regaining the level of preinjury movement. In addition, the malposition of the femoral tunnel was an important cause of cumulative failure.
format Online
Article
Text
id pubmed-7928216
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Clinical Journal of Sport Medicine
record_format MEDLINE/PubMed
spelling pubmed-79282162021-03-22 Medium-Term (Least 5 Years) Comparative Outcomes in Anterior Cruciate Ligament Reconstruction Using 4SHG, Allograft, and LARS Ligament Su, Mengdi Jia, Xinyu Zhang, Zaihang Jin, Zhigao Li, Yong Dong, Qirong Xu, Wei Clin J Sport Med Original Research OBJECTIVE: To compare the clinical efficacy of anterior cruciate ligament (ACL) reconstruction with 4-strand hamstring tendon autograft (4SHG), allograft and the Ligament Advanced Reinforcement System (LARS) ligament, and to find the causes of cumulative failure or nonreturn to sport. DESIGN: Retrospective case series. SETTING: Department of Orthopedic Surgery, the second affiliated hospital of Soochow University, Suzhou, Jiangsu, China. PATIENTS: Three hundred six patients with isolated ACL deficiency were included. Two hundred twenty-nine patients met the inclusion/exclusion criteria, and finally, 185 of these patients participated in this study. INTERVENTIONS: Anterior cruciate ligament reconstruction using 4SHG, allograft, and LARS. MAIN OUTCOME MEASURES: Objective knee function, subjective knee function, and information regarding return to sport, cumulative failure, and complications. Secondary: distribution of tunnel position and tunnel enlargement. RESULTS: There were no statistically significant differences between the 3 groups regarding all the clinical objective and subjective results, return to sport, complications, or cumulative failures (P > 0.05). One hundred twenty-eight patients (69.2%, 128/185) returned to sport. Preoperative (after injury) Tegner scores were inferior to postoperative Tegner scores, and postoperative Tegner scores were inferior to preinjury Tegner scores (P < 0.01). The femoral tunnel malposition was significantly associated with cumulative failure (P < 0.05). CONCLUSIONS: There were no statistically significant differences among the 4SHG, allograft, and LARS ligament in terms of the clinical outcomes after ACL reconstruction (ACLR) at 5-years follow-up. Interestingly, ACLR could improve the functional and motorial level of the knee, but patients had great difficulty in regaining the level of preinjury movement. In addition, the malposition of the femoral tunnel was an important cause of cumulative failure. Clinical Journal of Sport Medicine 2021-03 2019-03-14 /pmc/articles/PMC7928216/ /pubmed/30855342 http://dx.doi.org/10.1097/JSM.0000000000000730 Text en Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Research
Su, Mengdi
Jia, Xinyu
Zhang, Zaihang
Jin, Zhigao
Li, Yong
Dong, Qirong
Xu, Wei
Medium-Term (Least 5 Years) Comparative Outcomes in Anterior Cruciate Ligament Reconstruction Using 4SHG, Allograft, and LARS Ligament
title Medium-Term (Least 5 Years) Comparative Outcomes in Anterior Cruciate Ligament Reconstruction Using 4SHG, Allograft, and LARS Ligament
title_full Medium-Term (Least 5 Years) Comparative Outcomes in Anterior Cruciate Ligament Reconstruction Using 4SHG, Allograft, and LARS Ligament
title_fullStr Medium-Term (Least 5 Years) Comparative Outcomes in Anterior Cruciate Ligament Reconstruction Using 4SHG, Allograft, and LARS Ligament
title_full_unstemmed Medium-Term (Least 5 Years) Comparative Outcomes in Anterior Cruciate Ligament Reconstruction Using 4SHG, Allograft, and LARS Ligament
title_short Medium-Term (Least 5 Years) Comparative Outcomes in Anterior Cruciate Ligament Reconstruction Using 4SHG, Allograft, and LARS Ligament
title_sort medium-term (least 5 years) comparative outcomes in anterior cruciate ligament reconstruction using 4shg, allograft, and lars ligament
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928216/
https://www.ncbi.nlm.nih.gov/pubmed/30855342
http://dx.doi.org/10.1097/JSM.0000000000000730
work_keys_str_mv AT sumengdi mediumtermleast5yearscomparativeoutcomesinanteriorcruciateligamentreconstructionusing4shgallograftandlarsligament
AT jiaxinyu mediumtermleast5yearscomparativeoutcomesinanteriorcruciateligamentreconstructionusing4shgallograftandlarsligament
AT zhangzaihang mediumtermleast5yearscomparativeoutcomesinanteriorcruciateligamentreconstructionusing4shgallograftandlarsligament
AT jinzhigao mediumtermleast5yearscomparativeoutcomesinanteriorcruciateligamentreconstructionusing4shgallograftandlarsligament
AT liyong mediumtermleast5yearscomparativeoutcomesinanteriorcruciateligamentreconstructionusing4shgallograftandlarsligament
AT dongqirong mediumtermleast5yearscomparativeoutcomesinanteriorcruciateligamentreconstructionusing4shgallograftandlarsligament
AT xuwei mediumtermleast5yearscomparativeoutcomesinanteriorcruciateligamentreconstructionusing4shgallograftandlarsligament